Acquisition to enhance depth, breadth and value of services offered to pharmaceutical and biotech clients of both organizations
Prescient, a biopharma product and portfolio strategy firm, announced Tuesday the recent acquisition of Strategic North, a global commercial strategy consultancy that partners with a wide range of pharmaceutical companies to help them better understand how their customers make decisions in order to unlock the full potential of their brands.
Strategic North was founded in 2010 and today employs 70 executives out of its offices in the UK. The firm specializes in supporting Global Marketing, New Product Planning and Insight functions in the development of brand value propositions, positioning and messaging, and the rollout of global strategy to affiliates. Once a brand is in market, Strategic North works closely with Global and Regional Marketing teams to ensure that the value proposition continues to resonate and maintain differentiation. The firm continues providing support through clients' annual brand planning processes, ensuring their decisions are evidence-based, value-adding and future-proofed. Central to Strategic North's exceptional brand strategy expertise is its ability to develop deep insight into the behaviors and needs of key stakeholders, including prescribers, payers, patients, providers and advocacy groups.
